Celgene’s Budding Blockbuster Abraxane Scoops Pancreatic Cancer Indication

Abraxane sales have been growing fast as Celgene has added new indications. Pancreatic cancer had been an off-label use prior to the new approval.

More from Clinical Trials

More from R&D